enGene Holdings Inc. Warrants
General ticker "ENGNW" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.4B (TTM average)
enGene Holdings Inc. Warrants follows the US Stock Market performance with the rate: 43.4%.
Estimated limits based on current volatility of 6.2%: low 2.20$, high 2.49$
Factors to consider:
- Total employees count: 33 as of 2023
Short-term ENGNW quotes
Long-term ENGNW plot
Financial data
| YTD | 2025-10-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $123.17MM |
| Operating Income | $-123.17MM |
| Non-Operating Income | $5.86MM |
| Interest Expense | $2.99MM |
| R&D Expense | $94.48MM |
| Income(Loss) | $-117.30MM |
| Profit(Loss)* | $-117.30MM |
| Stockholders Equity | $167.71MM |
| Assets | $221.47MM |
| Operating Cash Flow | $-99.24MM |
| Capital expenditure | $1.49MM |
| Investing Cash Flow | $-25.14MM |
| Financing Cash Flow | $1.52MM |
| Earnings Per Share** | $-2.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.